Navigation Links
Valeant Pharmaceuticals Announces Closing of Public Offering of Common Shares
Date:6/24/2013

LAVAL, Quebec, June 24, 2013 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) reports the closing of its recently priced public offering (the "Offering") of common shares and the exercise in full by the underwriters of their option to purchase additional common shares.  The Company today issued 23,529,412 common shares at a price of $85.00 per share (the "Firm Shares") and, pursuant to the underwriters' exercise of their option to purchase additional common shares, an additional 3,529,412 common shares at a price of $85.00 per share (the "Additional Shares"), for aggregate gross proceeds of approximately $2.3 billion.

The Company intends to use the net proceeds from the Firm Shares sold in the Offering, together with its previously announced debt financing, to fund (i) the consideration of its previously disclosed acquisition (the "Merger") of Bausch + Lomb Holdings Incorporated ("B+L"), (ii) the fees and expenses incurred in connection with the Merger; and (iii) the repayment or retirement of B+L's outstanding debt. The Company may use the proceeds from the Additional Shares sold in the Offering, in addition to the manner described above, for general corporate purposes. If the Merger were not to close for any reason, the proceeds of the Offering, including the proceeds from such Additional Shares sold, will be used for general corporate purposes, which may include providing working capital, funding capital expenditures or for making one or more future acquisitions.

Goldman, Sachs & Co. will act as sole manager of the Offering outside of Canada and Goldman Sachs Canada Inc. will act as sole manager of the Offering in Canada. 

A copy of the final prospectus supplement and accompanying prospectus relating to the Offering in the United States'/>"/>

SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Valeant Pharmaceuticals Agrees To Acquire AcneFree And Certain Assets From University Medical
2. Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results
3. Valeant Pharmaceuticals To Host Investor Day
4. Valeant Pharmaceuticals To Announce 2012 Second Quarter Results On August 2, 2012
5. Valeant Pharmaceuticals International, Inc. Agrees To Acquire Medicis Pharmaceutical Corporation For $44.00 Per Share In Cash
6. Valeant Pharmaceuticals To Present At UBS Annual Global Life Sciences Conference
7. Valeant Pharmaceuticals Announces Management Change
8. Valeant Pharmaceuticals To Syndicate Incremental Loans
9. Valeant Pharmaceuticals Appoints Howard Schiller To Board Of Directors
10. Valeant Pharmaceuticals Announces Launch of Concurrent Private Offerings of Senior Notes
11. Valeant Pharmaceuticals International, Inc. Announces Pricing Of Concurrent Private Offerings Of Senior Notes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... -- New data demonstrates that flibanserin, a novel, non-hormonal medicine ... sexual dysfunction, Hypoactive Sexual Desire Disorder (HSDD), does not ... women when taken at bedtime. The data was presented ... America,s (SMSNA) 20th Annual Fall Scientific Meeting ... SMSNA accepted this study as a late breaking abstract ...
(Date:11/22/2014)... -- MEDITE Group acquired by CytoCore, Inc. (OTCBB: CYOE) on ... quarter sales ended September 30, 2014 of $8.7 million ... months ended September 2014 and a $38,000 loss for the ... quarter is usually a seasonable weak period due to the ... many countries worldwide, we are proud to announce record sales ...
(Date:11/21/2014)... PARK, Md. , Nov. 21, 2014  The ... today will host the ceremonial groundbreaking of the new ... College Park. The new building will cultivate transformative new ... health.  Taking place at 10:00 a.m. on ... in the Paint Branch Parking Lot, adjacent to the ...
Breaking Medicine Technology:Study on Efficacy and Sedation-Related Safety of Flibanserin in Premenopausal Women Released Today at Sexual Medicine Society of North America Meeting 2Study on Efficacy and Sedation-Related Safety of Flibanserin in Premenopausal Women Released Today at Sexual Medicine Society of North America Meeting 3CytoCore Inc. / MEDITE Cancer Diagnostics, Inc. Reports Record YTD and 3rd Quarter Sales 2CytoCore Inc. / MEDITE Cancer Diagnostics, Inc. Reports Record YTD and 3rd Quarter Sales 3University of Maryland Breaks Ground for A. James Clark Hall 2University of Maryland Breaks Ground for A. James Clark Hall 3University of Maryland Breaks Ground for A. James Clark Hall 4
... THOUSAND OAKS, Calif., July 15, 2011 Amgen ... the United States (U.S.) District Court in Pennsylvania ... against Teva Pharmaceutical Industries Ltd. and Teva Pharmaceuticals ... to human G-CSF (granulocyte colony-stimulating factor) and methods ...
...   Shire plc (LSE: SHP, NASDAQ: ... second quarter 2011,earnings on Thursday July 28, 2011. ... / 07:00 EDT Investor conference call time: 14:00 BST / ... Angus Russell, Chief Executive Officer and Graham Hetherington,Chief Financial Officer ...
Cached Medicine Technology:Amgen Resolves G-CSF Patent Litigation With Teva 2Shire plc : Second Quarter 2011 Results Date Notification - July 28, 2011 2
(Date:11/24/2014)... Volpara Solutions announced today that ... 100th Annual Meeting of the Radiology Society of ... Booth 1752 – South Hall). Volpara Solutions will ... rest of its innovative suite of quantitative breast ... personalized measurements of volumetric density, patient-specific dose, breast ...
(Date:11/24/2014)... (PRWEB) November 24, 2014 Recently, SweetDressy.com, ... industry, unveiled its new collection of 2014 Evening Dresses. ... now. According to the company’s marketing manager, the special ... http://www.sweetdressy.com/evening-dresses.html for more. , Sweetdressy.com has been working ... pleased to unveil the latest designs. Their new dresses ...
(Date:11/24/2014)... 24, 2014 SafeHandles™ announced that they ... with Ed Begley Jr, airing via Discovery Channel. Dates ... provide a passive, non-invasive, replaceable, and affordable germ protective ... custom-fit shrinkable sleeves and adhesives to promote hand hygiene ... the core of SafeHandles is the desire to make ...
(Date:11/23/2014)... Dallas, TX (PRWEB) November 24, 2014 ... Trials Review, H2, 2014" provides data on the ... information and data relating to the clinical trials ... trial numbers and their recruitment status as per ... The databook offers a preliminary coverage of disease ...
(Date:11/23/2014)... 2014 Pro Ace Care, a renowned Vancouver ... now be providing an 8 year warranty on its selected ... installations went up due to the impending winter season, it ... of the premium service that the company provides. As a ... on John Wood and Bradford hot water tanks. , ...
Breaking Medicine News(10 mins):Health News:Volpara Solutions to Launch VolparaAnalytics 1.2 at RSNA 2Health News:Volpara Solutions to Launch VolparaAnalytics 1.2 at RSNA 3Health News:SweetDressy.com Unveiled A New Selection Of Evening Dresses 2Health News:New Episode of Innovations TV Series to Feature SafeHandles™ 2Health News:Aspergillosis Pipeline and Clinical Trials Market (Compnies and Drugs) Review H2 2014 Report at ReportsnReports.com 2Health News:Aspergillosis Pipeline and Clinical Trials Market (Compnies and Drugs) Review H2 2014 Report at ReportsnReports.com 3Health News:Aspergillosis Pipeline and Clinical Trials Market (Compnies and Drugs) Review H2 2014 Report at ReportsnReports.com 4Health News:Pro Ace Care Now Gives 8 Year Guarantee on Selected Vancouver Hot Water Tanks 2
... in the walls of arteries − is thought of as ... number of young men and women, according to a new ... apparently healthy adults who are presumably ,the picture of health, ... an interventional cardiologist at the Institut universitaire de cardiologie et ...
... By Amanda Gardner HealthDay Reporter , MONDAY, ... soda seem to be prone to violence, new research suggests. ... not the direct cause of the aggression. While there,s ... contributes to violent behavior, the study shows an association, not ...
... in rural areas face unique challenges concerning health and wellness ... are more likely than women living in cities to be ... the disease. "The stage at which the cancer is ... recovery and survivability," said Faustine Williams, a doctoral student in ...
... MONDAY, Oct. 24 (HealthDay News) -- For the millions of ... taking the pills at bedtime may be best. It ... of the day can affect patients, blood pressure patterns, but ... study included 661 patients with chronic kidney disease and hypertension. ...
... By Jenifer Goodwin HealthDay Reporter , MONDAY, ... high levels of bisphenol A (BPA) while in their mother,s ... and emotional problems as toddlers, new research finds. BPA ... products. In the study, 244 mothers gave urine samples that ...
... MONDAY, Oct. 24 (HealthDay News) -- New research suggests that ... in patients with the most common form of lung cancer ... The combined treatment for non-small cell lung cancer was tested ... through more research, as experimental drugs go through three phases ...
Cached Medicine News:Health News:Young, apparently healthy -- and at risk of heart disease 2Health News:Young, apparently healthy -- and at risk of heart disease 3Health News:Soft Drinks Linked to Violent Tendencies in Teens: Study 2Health News:Soft Drinks Linked to Violent Tendencies in Teens: Study 3Health News:Rural women more likely to be diagnosed with most serious form of breast cancer 2Health News:Taking Blood Pressure Meds at Bedtime May Be Better 2Health News:BPA Exposure in Womb Linked to Behavioral Woes in Girls 2Health News:BPA Exposure in Womb Linked to Behavioral Woes in Girls 3Health News:Experimental Vaccine Shows Promise for Lung Cancer: Study 2
Shielding's Fast Wrap Apron offers both comfort and ease of wearing. Adjustable back shoulder strap keeps apron snug. No ties or buckles....
Shielding's Economy Coat Apron offers the same features as our Standard Coat Apron with an open back allowing for freedom of movement, maximum flexibility and increased comfort....
Lap pad used to protect pelvic regions...
The front of this apron is tapered for maximum adjustability as needed. We can include a specially designed half-apron to be worn under the full apron for double protection in the abdomen/pelvic cav...
Medicine Products: